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This is a case presentation of a patient with confirmed coronavirus disease (COVID-19) who ended 
his life with suicide by hanging. We are presenting the history of the disease, a clinical feature, the 
onset of the psychiatric symptoms and finally the pathological feature. Aims are: to perceive, in which 
phase of the disease occurred the psychiatric symptoms and eventually their connection with some 
morphological feature of the brain; to evaluate the changes of the primary disease to internal organs and 
finally, the ethical aspect i.e. how are these patients protected by the health care system. Results: patient 
committed suicide on the 12th day of the disease and around the 21st day after the infection, looking by 
its serum antibodies. On lungs dominated the picture of acute restrictive pulmonary disease and ARDS 
(acute respiratory distress syndrome) with strong inflammatory answer. A psychiatric disorder occurred 
with the epilog of double suicide attempt, of which the second one was successful. 
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Introduction
Of imminent importance and the main aim of this report is to present, in which phase of 
the disease occurred the onset of the psychiatric symptoms, in a person with no previous 
history of psychiatric illness, and if there has been found some morphological feature 
of the brain, underlining these symptoms. A wide discussion exists between medical 
professionals about that, if COVID-19 is causing some neurological and psychiatric 
disturbances, which are actually connected with some morphological manifestation of 
the disease on the CNS (central nervous system) [8, 9].  
The second aim of this paper comes out by the fact that, the patient didn’t die 
due to COVID-19 itself, but died of a violent death, which in turn has been found as a 
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special challenge during the examination of the internal organs. We expected to see the 
typical pathological feature of a developed COVID-19 disease, often described before 
[3, 5, 8,14] with no feature characteristic for the terminally ill patients, which more or 
less can mask and mimic the feature of the primary disease. 
Finally, one of the important aspects of this paper is the ethical one. Are COVID 
patients protected enough by the health care system, having in regard the pretty diverse 
and still very unknown, in fact not explored enough yet, clinical manifestation of this 
disease.  
Material and Methods
Presentation of the case
By the order of the public prosecutor, a body of a 39 years old man has been admitted to 
the Institute of forensic medicine for forensic autopsy, because of the obviously violent 
death i.e. suicide by hanging. During the collection of the data before the autopsy, 
we realized that the deceased was confirmed COVID-19 patient, who was receiving 
medical treatment for the disease. In fact, as shown by the records, death by suicide 
occurred 12 days since the beginning of the illness. 
History of the illness
Day 1 (12 days before death). The illness has started with mild to moderate symptoms: 
raised temperature to 38°C, feeling of exhaustion and muscle pain. After two to three 
days he was advised by his family doctor to make PCR COVID-test.  
Day 5 Patient had problems to schedule for a PCR-test in his own city (he was 
living in the capital city), so he decided to make test in the city about 40 km far from the 
capital. He signed the statement that from the moment of giving material for testing, he 
is going to be in self-isolation. 
Day 7 Still waiting for the result from the SARS CoV-2 molecular biology testing, 
the patient decided to visit the City hospital, one of the three centers for COVID-19 in 
the capital city. By that time, he developed respiratory symptoms, difficulty breathing, 
feeling of chest pressure and also loosing of the sense for smell and taste. 
During his first admission to the City-hospital in the early hours of the day 7, 
patient has not been hospitalized, even the fact that he had positive radiological feature 
(bilateral pulmonary inhomogeneous consolidations in middle and basal parties, 
phrenic-costal sinuses free of liquid) and the CRP (C-reactive protein) of 97,5, the 
body temperature of 37,4ºC and saturation O2 of 96%. With the prescribed therapy 
(paracetamol, azythromycin, anticoagulants, vitamin C and probiotics) he was released 
for home treatment.
Meanwhile, he received positive result for SARS CoV-2, when, by the words of his 
wife, parallel to his breathing symptoms, he started to develop psychiatric symptoms 
like feeling very much scared, restless and with difficulty sleeping.
In the late hours on the day 7, the patient attempted his first suicide, by injecting 
himself subcutaneously a poison (some grass drying substance used in the agriculture), 
for what he has been admitted to the toxicology clinic, from where was readmitted to 
the COVID centre, and then was released home with an advice to consult the toxicology 
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clinic if symptoms of intoxication occur. This moment, by the records, saturation O2 
was 95%, body temperature was 38ºC and blood pressure was 110/70. 
Day 11 With the ambulance the patient has been urgently admitted to the COVID 
center because of developing symptoms of extreme psychomotor tension, anxiousness, 
sleeplessness and black thoughts. A psychiatric therapy has been prescribed (amp. 
Diazepam 10 mg for acute treatment and then: risperidone, escitalopram, biperidone 
and zolpidem) and the patient has been released at home again. 
Day 12 In the early morning hours, several hours after his last visit to the hospital, 
the patient committed a suicide by hanging. 
Results
Autopsy finding
On autopsy we found a body of a 39 years old male, with regular osteomuscular 
constitution. 
During the external examination dominated a feature of an asphyxiation death: 
subconjuctival hemorrhages, cyanosis, and the hanging mark in the neck region.
During the examination of the internal organs, some specific signs of inflammation 
of the pharynx, larynx and trachea haven’t been found except some petechial 
hemorrhages of the tracheal mucosa (Fig. 1a).
The lung finding was rich. Lungs have been voluminous, heavy and full of liquid, 
especially in the down and back parts and with compensatory hyperinflation in the 
upper parts. The lung tissue has been found as colorful, consolidated, and solid by its 
consistence. In the basal parts there have been zones of whitish color and like rubbery 
consistence and a lot of spot bleedings on the cut surface (Fig. 1b, c). Effusion of liquid 
hasn’t been found in the pleural and pericardial cavity, but a fibrin adhesion has been 
found on the pleura of the left lung and on the epicardium. 
No specific feature on the other internal organs, except the dark-colored kidneys 
and congestion of the internal organs as non-specific but typical signs of asphyxiation. 
Hanging has been established as a cause of death. 
Fig. 1a            Fig. 1b
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Histopathology
A significant pathohistological feature has been found on lungs presented as diffuse 
alveolar damage. There have been found zones of the consolidation of the lung tissue 
and next to them zones of hyperinflation, probably compensatory (Fig. 2a). It has been 
found the exudative phase of ARDS (acute respiratory distress syndrome), with diffuse 
alveolar damage, edema and cellular infiltration with leukocytes, lymphocytes and 
also desquamated pneumocytes (Fig. 2b). Also, the presence of the pulmonary micro 
Fig. 1. Findings of the examination of internal organs: a. spot bleedings of the tracheal mucosa; b. the 
appearance of lungs (voluminous, heavy and full of liquid); c. on cut surface tissue was colorful, 
consolidated, and solid by its consistence, with zones of whitish color and a lot of spot bleedings between.
Fig. 1c
Fig. 2a           Fig. 2b
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thrombi inside the blood vessels has been documented (Fig. 2c). Additionally, in some 
parts were seen signs of a transition to proliferative phase with the pneumocytes type 2 
hyperplasia and zones of the organization (Fig. 2d). 
No specific feature has been found to the other organs. Special attention has been 
paid to the brain tissue, where some signs of hypoxia have been found, but very unsure 
if they were result of the primary COVID disease or of the asphyxiation that has been 
found as the cause of death.  
Fig. 2c           Fig. 2d
Fig. 2. Histopathology of lungs presented as diffuse alveolar damage: a. consolidation zones of the 
lung tissue and next to them zones of hyperinflation, probably compensatory; b. exudative phase of 
ARDS, with diffuse alveolar damage, edema and cellular infiltration with leukocytes, lymphocytes 
and also desquamated pneumocytes; c. the presence of the pulmonary microthrombi inside the blood 
vessels; d. in some parts were seen signs of a transition to proliferative phase with the pneumocytes type 
2 hyperplasia and zones of the organization. 
Laboratory findings 
Intravital laboratory findings (received by medical records)
Day 7 laboratory results: CRP of 97,5; LDH (lactate dehydrogenase) of 267; 
CK (creatine kinase) of 246; ACT (aspartat transaminase) of 40; d-dimers of 21; mild 
leukocytosis of 12,8 with the domination of the granulocyte fraction. 
Radiology finding: inhomogeneous bilateral consolidations in the middle and basal 
parts, phrenicocostal sinuses have been free of liquid. 
Postmortem laboratory findings
By applying molecular diagnostics on the pharyngeal and tracheal swabs, a presence of 
SARS Cov2 has been confirmed. 
Additionally, detection of the anti-COVID antibodies has been undertaken. A 
positive result has been received for IgM antibodies with value of 30 AU/ml (referent 
value <1.00 AU/ml), and the positive result for IgG antibodies, with the value of 47,5 
AU/ml (referent value <1.00 AU/ml).
Detection of the antiCOVID IgM antibodies has been expected which has been 
proof of the developed and lasting COVID-19 disease, fully coinciding with the data 
received that the death occurred on the 12th day of the disease. The presence of the 
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antiCOVID IgG antibodies undoubtedly has shown that the infection existed at least a 
week longer than the onset of the symptoms.
Postmortem biochemical analyses have shown a moderately raised values of 
myoglobin and the serum troponin, as well as the enzymes Alcaline phosphatase, 
AST (aspartat aminotransferase), CK (creatin kinase), and more significantly raised 
values  of the LDH (lactate dehydrogenase), GAMA (glutamil transpeptidase) and ALT 
(alanine aminotransferase). Erythrocytes have been found 3,11×1012/L, hemoglobin of 
92g/L; leukocytosis of 14,9×109/L with the lymphocyte fraction of 6,3×109/L; as well 
as mildly raised thrombocytes of 594×109/L. 
Toxicology analysis has shown benzodiazepines in the blood with therapeutically 
values. 
Discussion
Coronavirus disease 2019 (COVID-19) first occurred in China by the end of 2019, 
but very fast has spread over the planet. The first confirmed case in USA has been 
on January 20, 2020 [3]. The first case in Republic of North Macedonia has been 
confirmed in the middle of February 2020. Until recently it has been a relatively new 
and unexplored disease with very diverse clinical picture. Some author concluded that 
severe COVID-19 form is a consequence of immune-mediated, rather than pathogen-
mediated organ injury [2]. That is why, autopsies are essential to understand all the 
organ alterations in COVID-19 [2, 5, 14]. 
This disease is represented by two phases. For the first phase of the disease are 
typical symptoms very much like influenza syndrome: muscle pain, headache and fatigue. 
In mild cases the disease stops here. If condition continues more than 7 days, then a 
second pulmonary phase sets in. Careful medical records and autopsy reports published 
worldwide have shown that coronavirus 2 (SARS-CoV-2) is actually organotropic to 
many other organs than lungs [4, 8, 10], especially involving the thrombotic system and 
causing a kind of coagulopathy [1]. 
In the case presented here, a 39 years old man committed suicide by hanging on 
the 12th day of the COVID-19 disease, which is the second pulmonary phase of the 
disease and at least 21 days after the contact with the coronavirus 2 (SARS-CoV-2), as 
shown by the anti- SARS-CoV-2 antibodies found in his blood. The clinical course of 
the disease developed as typical acute restrictive lung disease i.e. a virus pneumonia, as 
in detail described in the classic pathology books [7] with strong inflammatory answer, 
as seen by the laboratory indicators (CRP, LDH, transaminaze enzymes, etc.)
Psychiatric symptoms first occurred on the seventh day of the disease and have 
been strongly related with the receiving of the positive PCR (polymerase chain 
reaction) molecular testing results. Actually, on that day the patient has been admitted 
to the hospital and there is a medical record that then he had oxygen saturation of 96%. 
Unfortunately, we don’t have the exact recording of the oxygen saturation in the next 4 
days (from the seventh to twelfth day, when he committed suicide), because the patient 
hasn’t been hospitalized. 
That is the reason why, our analysis has been directed toward the possible changes 
and conditions that eventually can be considered as a morphological substrate for the 
occurring of the psychiatric symptoms, and the hypoxia as the most probable among 
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them. A question arose: can the hypoxia of the brain be the pathological substrate for the 
onset of the psychiatric symptoms in COVID-19 patients? 
During the 2020 there have been a lot of reports about the connection between 
COVID-19 and neurologic and also neuropsychiatric complications [9]: encephalopathy, 
meningo-encephalitis, ischemic stroke, acute necrotizing encephalopathy and Guillain-
Barre syndrome (GBS). 
Collecting the data from the 24 medical institutions in United Kingdom, in a study 
[8] has been described a wide range of the neurological complication in COVID-19 
patients. A total of 43 patients have been analyzed where five major categories 
of neurological conditions have been described: 1. Encephalopathy (n = 10) with 
delirium/psychosis and no distinct MRI or CSF abnormalities; 2. Inflammatory CNS 
syndromes (n = 12) including encephalitis; 3. Ischemic strokes (n = 8) associated with 
a pro-thrombotic state; 4. Peripheral neurological disorders (n = 8), and five patients 
with miscellaneous neurological complication who did not fit these categories. As a 
possible mechanisms have been described: the direct viral neuronal injury; a secondary 
hyperinflammation syndrome; postinfectious inflammatory or immune-mediated 
disorders; and also the effects of a severe systemic disorder with the neurological 
consequences of sepsis, hyperpyrexia, hypoxia, hypercoagulability and critical illness. 
Those conditions occurred in the period from 6 days before and up to 27 days following 
the onset of the COVID-19 symptoms. 
Upon that, the previous mentioned study shows that hypoxia of the brain can 
be found as a serious factor for the occurring of the neurological and the psychiatric 
disturbances. Examining the brain in the presented case some signs of hypoxia have 
been seen, but not clear if they are result of the primary disease or of the asphyxiation. 
The degree of the neurological disturbance often is not correlated with the severity of 
the primary COVID disease and also the neurological symptoms can be found as a 
first presentation of the COVID disease [6, 8]. Hence, it is a kind of challenge early 
recognizing and managing of the neurological and psychiatric disturbances in the 
COVID-19 disease. 
Based of the aforementioned, if we look back to the medical history of the 
presented case, in fact the patient has asked for a psychiatric support twice: first time, 
indirectly by his first attempt for suicide, and second time, four days later he and his 
family directly asked for it. Unfortunately, the patient has been released home only with 
the prescribed antipsychotic therapy. This event shows that, regarding the COVID-19 
patients, medical professionals must be aware about the neurological and psychiatric 
manifestation of the disease, as well as the possible consequences of it. 
The second important aspect of this case report is to perceive the pathological 
feature of the lungs in a confirmed COVID-19 patient, who actually didn’t die of the 
disease itself but of a violent death. The clinical data along with the pathological findings 
were pointing to the acute restrictive lung disease which started as an atypical viral 
pneumonia and then progressed to diffuse alveolar damage, known as ARDS (acute 
respiratory distress syndrome). 
The concept of the primary atypical pneumonia has been presented since 
1938 and described as non-productive pneumonia, with minimal physical and rich 
radiology findings, with predominantly good prognosis and bad outcome only in 
immunosuppressed organisms [7]. The bad outcome actually means the development 
toward the diffuse alveolar damage and ARDS. 
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Acute respiratory distress syndrome (ARDS) is a clinical syndrome defined 
in 1994 by the American-European Consensus Conference (AECC) which is 
characterized by: 1. acute respiratory distress, 2. decreased arterial oxygen pressure 
and 3. the development of diffuse pulmonary infiltrates on radiographs [7, 11, 12, 13]. 
By the Berlin Definition [11] there are proposed three categories of ARDS upon the 
severity: mild, moderate and severe, with strict parameters given. Diffuse alveolar 
damage is the morphologic counterpart of ARDS [7]. It is characterized by diffuse 
injury of the alveolar epithelial and capillary endothelial cells, accompanied with the 
pulmonary edema. 
In the pathogenesis of ARDS, no matter of the initiating agent (chemical, physical 
or viral), there is a sequence of the events: 1. endothelial and epithelial damage; 2. 
the cellular reaction by neutrophiles and macrophages; 3. releasing of the TNF-alpha 
(tumor necrotizing factor alpha) and activating of the complement with subsequent 
production and release of the cytokines, powerful mediators, proteases etc. which all 
further damage the endothelium and increase vascular permeability. These all cause 
the changes of the first or exudative phase of ARDS: interstitial and intraalveolar 
edema and hemorrhage, necrosis of the epithelial cells and forming of the typical 
hyaline membranes underlining the alveolar walls which sufficiently compromise 
the oxygenation. 72 hours after the process begins, a disseminated intravascular 
coagulation may become evident and complicate the clinical picture [7].  The next 
two phases in the morphology of ARDS are the proliferative phase characterized by 
the proliferation of the type II pneumocytes and fibroblasts, and finally the fibrotic 
phase with the progressive fibrosis involving the interstitial and alveolar spaces, 
leading to diffuse interstitial fibrosis (honeycomb lungs) [7]. 
In the presented case were found changes of the exudative and proliferative phase 
of ARDS. Having in regard that the mortality rate of ARDS nowadays is beneath 50% 
[13], comparing with the past when it was almost 100%, we can assume that if patient 
overcomes the exudative phase, there are good chances of survival. Implying that to 
the presented case, there are good chances that the person could have overcome the 
COVID-19 disease, but unfortunately he died of suicide. Here lies the obligation for 
the medical professionals to recognize the neurological and psychiatric disturbances 
as part of the diverse clinical picture of COVID-19, in order to provide a complete 
health care for the patient. 
Conclusion
This case presentation shows that the psychiatric and neurological disturbances can 
be significant part of the clinical picture of the COVID-19 disease and they are not 
necessarily correlated with the severity of the primary disease. Medical professionals 
must be aware of these manifestations of the COVID-19 disease, because sometimes 
they can be more fatal than the lung disease itself. High degree of caution and care are 
important in these cases. 
Having in regard the diverse and still not enough explored clinical manifestation 
of the COVID-19, besides treating the pneumonia and coagulopathy in these patients, 
attention to the psychiatric status of the patient must be paid, in order to enable him/her 
a complete health care protection. 
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